PAM
TAK icon

Pinpoint Asset Management’s Takeda Pharmaceutical TAK Stock Holding History

Pinpoint Asset Management’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-147,600
Closed -$2.05M – 129
2024
Q1 		$2.05M Buy
+147,600
New +$2.15M 0.33% 44

Other funds holding TAK

GAM
Groupama Asset Management Paris, France $6.85B AUM 43.37% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.69B AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Pinpoint Asset Management's TAK Position: Q2 2024 in Review

Pinpoint Asset Management sold out of Takeda Pharmaceutical (TAK) in Q2 2024, closing a stake of 147,600 shares — an estimated $2.05M sold.

Pinpoint Asset Management first reported a position in TAK in Q1 2024 and held it in 1 quarter. The position peaked at $2.05M in Q1 2024. 283 funds tracked by Wall St. Rank hold TAK as of Q2 2024.

  • Pinpoint Asset Management reported no remaining Takeda Pharmaceutical position as of Q2 2024 after selling out during the quarter.
  • Pinpoint Asset Management sold 147,600 Takeda Pharmaceutical shares in Q2 2024, an estimated $2.05M.
  • Pinpoint Asset Management first reported a position in Takeda Pharmaceutical in Q1 2024 and held it in 1 quarter.
  • Pinpoint Asset Management's Takeda Pharmaceutical position peaked at $2.05M in Q1 2024.
  • 283 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2024.

Based on Pinpoint Asset Management's 13F filing for Q2 2024, filed 14 Aug 2024.